Pages
- About us
- Archives
- CENTRAL SERVICES 2
- Centres
- Centre for Emerging Zoonotic and Parasitic Diseases
- Centre for Enteric Diseases
- Centre for Healthcare-associated Infections, Antimicrobial Resistance and Mycoses
- CENTRE FOR HIV AND STIs
- Centre for Quality Assurance
- Centre for Respiratory Diseases and Meningitis
- Centre for Tuberculosis
- Centre for Vaccines and Immunology
- Division of Public Health, Surveillance and Response
- National Cancer Registry
- SA Regional Global Diseases Detection Programme
- Sequencing Core Facility
- Communicable Diseases Surveillance Bulletin
- Contact us
- COUGHWATCHSA APPLICATION
- COVID-19 SUPER-SPREADER ALERT
- COVID-19 Vaccination: Reporting Adverse Effects FAQ
- COVID-19 Vaccine – How To Register
- COVID-19 Vaccine Breakthrough Cases Frequently Asked Questions
- COVID-19 Vaccine Rollout For Healthcare Workers – FAQ
- COVID-19 Vaccine Rollout Strategy FAQ
- COVID-19 Vaccine Side-Effects FAQ
- CRDM SARI Privacy policy
- CVI CURRENT PROJECTS
- Diseases A-Z Index
- Acinetobacter baumannii
- Acute flaccid paralysis (AFP)
- Acute rheumatic fever
- Adverse event following immunization (AEFI)
- Anthrax
- Antimicrobial Resistance
- Antimicrobial resistance maps
- Arbovirus
- Avian Influenza
- Bartonellosis
- Blastomycosis
- Botulism
- Brucellosis
- Bubonic plague
- Candida auris
- Carbapenamase resistant infection
- Carbapenem Resistant Enterobacteriaceae (CRE) and others
- Carbapenemase-producing Enterobacteriaceae (CPE)
- Chickenpox
- Chikungunya
- Cholera
- City of Tshwane Listeria health promotion tools
- Clostridium difficile infection
- Codex Alimenarius documents
- Congenital Rubella syndrome
- Congenital Syphilis
- COVID-19
- COVID-19 ADVICE TRAVELLERS
- COVID-19 ADVICE FOR THE PUBLIC
- COVID-19 frequently asked questions masks
- Pneumococcal conjugate vaccine use in the light of the COVID-19 pandemic
- What to do if I am a close contact of a person with confirmed disease and am asked to home quarantine?
- WHAT TO DO IF I TEST POSITIVE FOR CORONAVIRUS DISEASE AND I AM ASKED TO HOME ISOLATE?
- WHAT TO DO IF I THINK I HAVE COVID-19?
- COVID-19 Communication Resources
- COVID-19 contact resources
- COVID-19 FREQUENTLY ASKED QUESTIONS
- COVID-19 GUIDELINES
- ANTIGEN TESTING GUIDELINE
- CASE-FINDING, DIAGNOSIS, MANAGEMENT AND PUBLIC HEALTH RESPONSE
- CHILDCARE FACILITIES AND SCHOOLS
- CLINICAL MANAGEMENT OF SUSPECTED OR CONFIRMED COVID-19 DISEASE
- CONTAINMENT AND MANAGEMENT OF COVID-19 FOR SCHOOLS
- DISASTER MANAGEMENT ACT 57 of 2002
- ENVIRONMENTAL HEALTH GUIDELINE
- FABRIC FACE MASKS
- GUIDELINES ON POST MORTEM TESTING FOR NATURAL DEATHS
- INFECTION PREVENTION AND CONTROL GUIDELINES
- MEDICAL CERTIFICATION OF DEATHS DUE TO COVID-19
- NATIONAL INFECTION PREVENTION AND CONTROL STRATEGIC FRAMEWORK
- OUTBREAK RESPONSE AND INVESTIGATION IN HEALTH CARE FACILITIES
- PERSONAL PROTECTIVE EQUIPMENT SPECIFICATIONS
- PRACTICAL MANUAL FOR THE IMPLEMENTATION OF THE NATIONAL INFECTION PREVENTION AND CONTROL STRATEGIC FRAMEWORK
- REGULATION OF QUALITY RESPIRATORY PROTECTIVE EQUIPMENT SUPPLY IN HEALTHCARE
- ROUTINE IMMUNISATION SERVICES
- SUBMISSION OF COVID-19 RELATED HEALTH DATA FROM WORKPLACES
- SYMPTOMS MONITORING AND MANAGEMENT OF ESSENTIAL WORKERS FOR COVID-19 RELATED INFECTION
- COVID-19 INFORMATION FOR HEALTHCARE PROFESSIONALS
- COVID-19 Prevention
- COVID-19 RESOURCES FOR CHILDREN
- COVID-19 Situational Reports
- COVID-19 SURVEILLANCE REPORTS
- BI-Weekly Reports
- COVID-19 SPECIAL REPORTS
- DAILY HOSPITAL SURVEILLANCE (DATCOV) REPORT
- Daily Reports
- MODELLING CONSORTIUM (PROJECTIONS)
- MONTHLY COVID-19 IN CHILDREN
- NATIONAL COVID-19 DAILY REPORT
- PRIVATE CONSULTATIONS EXCESS RESPIRATORY ENCOUNTERS
- SPECIAL PUBLIC HEALTH SURVEILLANCE BULLETIN
- Special Reports
- WEEKLY RESPIRATORY PATHOGENS SURVEILLANCE REPORT WEEK
- WEEKLY EPIDEMIOLOGICAL BRIEF
- WEEKLY HOSPITAL SURVEILLANCE (DATCOV) UPDATE
- WEEKLY PRIVATE CONSULTATIONS EPIDEMIC THRESHOLD
- WEEKLY PROVINCIAL EPIDEMIOLOGY BRIEF
- Weekly Reports
- WEEKLY TESTING SUMMARY
- COVID-19 technical resources
- FREQUENTLY ASKED QUESTIONS: C.1.2 COVID-19 VARIANT
- LONG COVID
- SARS-CoV-2 GENOMIC SURVEILLANCE UPDATE
- Crimean-Congo haemorrhagic fever (CCHF)
- Cryptococcal disease
- Dengue fever
- Diphtheria
- Ebola virus disease
- Emergomycosis
- Enterobacteriaceae
- Enterococci
- Enteroviral Meningitis
- Epstein-Barr virus infection
- Foodborne illness and gastroenteritis outbreaks
- Gonorrhoea
- Haemophilus Influenzae type B
- Hand Foot and Mouth Disease
- Healthcare-Associated Infections (HAIs)
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis D
- Hepatitis E
- Histoplasmosis
- HIV
- Hospital infection outbreaks
- Influenza
- Klebsiella pneumoniae
- Lassa fever
- Legionella
- Leprosy
- Leptospirosis
- Lice
- Marburg
- Measles
- Meningitis
- Meningoccocal Disease
- Methicillin-Resistant Staphylococcus aureus (MRSA)
- Middle East respiratory syndrome coronavirus
- Monkeypox
- Mumps
- Myiasis
- NICD – Listeriosis
- NICD Disease Index – Malaria
- NICD-Carbapenam-resistant bacteria
- Novel respiratory pathogen
- Peduculosis
- Pertussis
- Pneumococcal infection
- Pneumococcus
- Poliomyelitis
- Pseudomonas aeruginosa
- Rabies
- Rift Valley Fever
- Rotavirus infection
- Rubella
- Salmonellosis
- SARS
- Scarlet fever
- Schistosomiasis (Bilharzia)
- Sexually Transmitted Infections (STIs)
- Shigellosis
- Sindbis fever
- Smallpox
- Staphylococcus aureus
- staphylococcus infection
- Streptococcal pharyngitis
- Tetanus
- Tick bite fever
- Tuberculosis
- Tuberculosis: drug-resistant
- Typhoid fever
- Vaccines
- Varicella Zoster Virus
- Viral haemorrhagic fever (VHF)
- West Nile fever
- Yellow fever
- Zika virus disease
- DIVISION OF BIOSAFETY AND BIOSECURITY
- Enteric Diseases Publication
- FAQs
- FETP FRONTLINE COURSE
- GERMS
- Health Awareness
- HIV&STI’S CURRENT PROJECTS
- Home
- Home-IWW
- Homepage Idea 1
- Internal Publications
- Lujo
- Media
- Newsletter
- NICD Communiqué 2018
- NMC NOTIFICATIONS APP PRIVACY POLICY
- NOTIFIABLE MEDICAL CONDITIONS
- Our Services
- Communications
- Diagnostic Services
- International
- Outbreak Response
- Proficiency Testing Schemes
- Research
- Surveillance
- Training
- Field Epidemiology Training Programme (FETP)
- Intensive courses in Mycology, Parasitology and Virology
- Intern Scientist Training Programme
- SAFETP Achievements
- SAFETP Leadership and Team
- SAFETP News
- SAFETP Objectives
- SAFETP Our Partners
- SAFETP Programmes
- The South African Field Epidemiology Training Programme
- Three-week Communicable Diseases Rotation
- Plague
- Publications
- Publications (Training)
- QUALITY ASSURANCE
- Returning to Work FAQs
- SAFETP NEWS ARCHIVE
- Scientific Publications
- Centre for Emerging, Zoonotic and Parasitic Diseases
- Centre for Enteric Diseases
- Centre for Healthcare Associated Infections, Antimicrobial Resistance and Mycoses
- Centre for HIV and STIs
- Centre for Respiratory Diseases and Meningitis
- NICD Centre for Tuberculosis
- NICD Centre for Vaccines and Immunology
- Scientific Publications-National Cancer Registry
- SEQUENCING CORE FACILITY
- Sitemap
- Soil Transmitted Helminths
- Special Publications
- Terms & Conditions
- The COVID-19 Vaccine and The Flu Vaccine
- TRANSVERSAL FUNCTIONS
- TUTORIAL VIDEOS
- Vacancies
- Weekly Influenza and Respiratory Syncytial Surveillance Report
- What You Need To Know About The COVID-19 Vaccine
- What You Need To Know About Vaccines In General
- What You Need To Know Once You’ve Been Vaccinated
- Who Can Get The COVID-19 Vaccine
